Shanghai-based clinical-stage biopharmaceutical company- JW Therapeutics has raised US$100 million in a series B round financing co-led by CPE and Mirae Asset. The total funding amount of…
Latest News on Startups from emerging markets catered towards Japan
Shanghai-based clinical-stage biopharmaceutical company- JW Therapeutics has raised US$100 million in a series B round financing co-led by CPE and Mirae Asset. The total funding amount of…